Finance

Lists
311690:KOSDAQ
CJ Bioscience Inc
â‚©3,710.00
+0.13%
(+5.00) 1D
Sep 23, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 311690...
Open
â‚©3,795
High
â‚©3,795
Low
â‚©3,595
Mkt. cap
48.47B
Avg. vol.
5.24K
Volume
6.90K
52-wk high
â‚©10,280
52-wk low
â‚©3,060
EPS
-â‚©1,709
Shares outstanding
13.07M
No. of employees
122
Open
â‚©3,795
High
â‚©3,795
Low
â‚©3,595
Mkt. cap
48.47B
Avg. vol.
5.24K
Volume
6.90K
52-wk high
â‚©10,280
52-wk low
â‚©3,060
EPS
-â‚©1,709
Shares outstanding
13.07M
No. of employees
122
About CJ Bioscience Inc
CEO-
Employees122
Founded2009
Headquarters-
SectorHealth care
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
737.90M
1.26B
783.07M
898.15M
Cost of goods sold
694.95M
913.35M
648.09M
702.69M
Cost of revenue
694.95M
913.35M
648.09M
702.69M
Research and development expenses
4.57B
4.20B
3.35B
4.59B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.24B
1.02B
1.70B
1.66B
Operating expense
6.12B
5.50B
5.48B
6.59B
Total operating expenses
6.82B
6.42B
6.13B
7.30B
Operating income
-6.08B
-5.16B
-5.34B
-6.40B
Other non operating income
6.71M
499.18K
214.40M
191.42M
EBT including unusual items
-5.83B
-5.16B
-5.13B
-6.21B
EBT excluding unusual items
-5.79B
-4.91B
-5.13B
-6.21B
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
12.88M
28.29M
103.55M
22.63M
Net income
-5.83B
-5.16B
-5.13B
-6.21B
Net profit margin
-789.91%
-410.42%
-654.82%
-691.19%
Earnings per share
-
-
-
-
Interest and investment income
422.23M
379.18M
-
-
Interest expense
-132.69M
-127.06M
-
-
Net interest expenses
289.54M
252.11M
-
-
Depreciation and amortization charges
301.58M
249.36M
312.15M
318.14M
EBITDA
-5.08B
-4.17B
-4.44B
-5.47B
Gain or loss from assets sale
42.04M
251.70M
-
-
AI content may include mistakes. Learn more
Google apps